AJ

Amit Joshi

Active Director Director DIN 01889574
DIN 01889574 First appointment Aug 2002 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2002
Shareholding value •••• Premium profile

About Amit Joshi

Data last updated:

Amit Joshi is a Director at Monad Pharmaceuticals Private Limited (since 2002). The company operates in Healthcare. Monad Pharmaceuticals Private Limited reported revenue of ₹82.6 Lakh (FY 2017).

DIN 01889574
Primary Designation Director
Industry Healthcare
First Appointment 20 Aug 2002
Oldest Company Age 24 yrs
Largest company Monad Pharmaceuticals Private Limited · ₹82.6 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Aug 20022002₹82.6 Lakh (FY 2017)Active

Board colleagues of Amit Joshi

NameDINCompanyDesignation
Vikas Bharti01686068Monad Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Monad Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Amit Joshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amit Joshi

Amit Joshi currently holds 1 directorship: Monad Pharmaceuticals Private Limited (Director, since 20 Aug 2002, revenue ₹82.6 Lakh (FY 2017)).

Amit Joshi was first appointed on 20 Aug 2002 as Director at Monad Pharmaceuticals Private Limited.

The current boards of Amit Joshi's companies include Vikas Bharti (Monad Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available